Related Articles
PLEKHS1: A new molecular marker predicting risk of progression of non‑muscle‑invasive bladder cancer
Three-gene signature predicts disease progression of non-muscle invasive bladder cancer
A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
IL‑23 concentration‑dependently regulates T24 cell proliferation, migration and invasion and is associated with prognosis in patients with bladder cancer
Clinical significance of α‑ and β‑Klotho in urothelial carcinoma of the bladder